Founded by Professor Ed Southern, Oxford Gene Technology (OGT) is focused on providing innovative genetics research and biomarker solutions to advance molecular medicine.
The company has three core commercial arms: Genomics, Biomarkers and Licensing. In addition, an Exploratory Research division, headed by Professor Southern, focuses on developing new diagnostic techniques with potential for in-house commercialisation or partnering with diagnostic and pharmaceutical organisations.
With its clear strategic focus, OGT has invested significantly in highly qualified expertise, doubling the workforce over the last 2 years to over 60 people. In anticipation of this rapid expansion, OGT moved to a new, purpose-built facility located in the Begbroke Science Park near Oxford, UK. These strategic decisions have resulted in strong year-on-year revenue growth across all business units. The company plans further expansion fuelled by growth into the clinical research market, a full pipeline of new products and further corporate development opportunities.
OGT’s highly experienced management team are driving this growth through end-user sales and by forging strong relationships with major international corporations including Agilent, Illumina and Roche.